Bayer Ag · XETR:BAYN
Bayer — EURETINA 2023 (European Society of Retina Specialists annual meeting)
12 slides from Bayer's conference presentation, October 2023
Slide 1: Presented at EURETINA annual meeting, 5–8 October 2023, Amsterdam
Presented at the European Society of Retina Specialists (EURETINA)’s annual meeting, 5–8 October, 2023, Amsterdam, The Netherlands
Slide 2: Financial disclosures and acknowledgments
DR . a nAMD Be ter Financial disclosures and acknowledgments nAMD 4 Overcoming Barriers Focke Ziemssen: Travel grants and personal fees: Allergan/AbbVie, Alimera, Bayer Healthcare, Biogen, Boehringer Ingelheim, Clearside, Janssen, Novartis, Novo Nordisk, MSD Sharp & Dohme, Regeneron, Roche/Genentech
Slide 3: Survey objectives and design
DR jecti nAMD Jy Paceater Survey objectives and design Baromet& Shift e needle Overcoming Barriers Problem: There are significant challenges, such as adherence to treatment, clinic capacity constraints, and financial limitations, associated with routine clinical management of DR and DME that may imp
Slide 4: Individual questionnaires for respondents
AM. . . nts Baromete . ires for responde Barome vidual questionna Bh | —— - pR® Indi q amina Rarriers, Additional information from any of these sources to (or your eye treatment? resources on i “scale titers | ikert-sca International patient organization’s websites (e.g. International Diabetes Feder
Slide 5: Global Survey: respondents for the DR/DME survey
nAMD Ay Barometer Global Survey: respondents for the DR/DME survey DR. Barometer C ne needle Croatia Germany France Portugal Greece Switzerland a= == + | Russia Shifti 29 200 60 212 200 57 United Arab Saudi Emirates Israel Arabi: ay | a | comme 68 133 61 Turkey Kuwait — 292 177 China Mexico of 1151
Slide 6: Survey participation and analysis
Survey participation and analysis nAMD 4> Overcoming Barriers Self-reported adherence of Data: 8216 respondents comprising: 4 patients with DME? 181 3752 patients with DME 2535 patients with DR © 680 providers 1249 clinic staff = Adherent = Non-adherent = Missing adherence status Adherence: 17.9% of
Slide 7: Do patients understand their disease and treatment?
DR Do patients understand their disease and treatment? nAMD Jy Barometer Barometer Shifting the needle Overcoming Barriers Did you receive clear information about what DME is and what to expect over time with treatment? For patients with DME: 28.7% reported not really understanding their disease and
Slide 8: Providers were asked how frequently they discuss key topics
DR. Barometer Providers were {> Disease The risk that DR/DME can result in vision loss (59.9%) The correlation between diabetes and risk of complications (58.4%) A basic explanation of DR/DME (57.2%) How improving diabetes control can reduce disease progression (56.2%) asked how frequently they disc
Slide 9: Are we missing an important part of the appointment burden story?
S. . . nAMD & DR ter Are we missing an important part of the AMD 4’ . Overcoming Barriers appointment burden story? , Shifting the needle For patients with DME: 42.8% said that there were too many diabetes appointments 45.0% said that there were too many eye appointments When patients were asked abo
Slide 10: Opportunities identified by patients to better support them with DME
& Baccsneter Opportunities identified by patients to nAMD > Overcoming Barriers mee better support them with DME Access to treatment My doctor proactively discussing challenges | may face (83.7%) Longer time between treatments without losing vision (74.3%) Always having the same clinic team treating
Slide 11: How can these novel findings enhance patient-focused care?
S. rr AMD DRS er How can these novel findings enhance Barone otra veneers patient-focused care? This survey provides unique, quantifiable insights into the scale and breadth of the key challenges patients face from various perspectives. The persistent worldwide appointment and disease burden uncover
Slide 12: Thank you to all survey participants and centers!
Barometer e Overcoming Barriers Barometer Thank you to all survey participants and centers! naMD/ > (— Survey centers: > Australia: Sydney West Retina, Australian Eye Specialists, Retina Specialists Victoria. Brazil: Hospital Oftalmologico de Sorocaba, Hospital de Olhos de Araraquara, Centro de Refe
Bayer — EURETINA 2023 (European Society of Retina Specialists annual meeting) on 6ix